Advertisement

 

 

Report of 12 Cases with tracheobronchial mucormycosis and a review.

Report of 12 Cases with tracheobronchial mucormycosis and a review.
Author Information (click to view)

He R, Hu C, Tang Y, Yang H, Cao L, Niu R,


He R, Hu C, Tang Y, Yang H, Cao L, Niu R, (click to view)

He R, Hu C, Tang Y, Yang H, Cao L, Niu R,

Advertisement

The clinical respiratory journal 2017 10 13() doi 10.1111/crj.12724
Abstract
OBJECTIVES
Tranchobronchial mucormycosis is a rare and invasive pulmonary mucormycosis involving the tracheobronchial tree.

DATA SOURCE
at a 3500-bed tertiary care center.

STUDY SELECTION
This was a retroactive study of 12 cases of tranchobronchial mucormycosis diagnosed in our hospital, and 48 cases that were previously reported in the English literature.

RESULTS
Rhizopus was the predominant species of pathogen (66.7%). Primary bronchus was the most frequently involved location (38.2%), and upper lobes (51% of cases) were a predilection. Obstructive necrosis and mucosal necrosis were the most common pathological forms (40% and 34.5%, respectively). Fever (59.3%), cough (59.3%), dyspnea (40.7%), and hemoptysis (30.5%) were the most common symptoms. 51.4% patients had rales, 40% had moist rales, and 28.6% had negative physical findings. 95% patients had immunosuppressive diseases. Diabetes mellitus (66.7%), diabetes ketoacidosis (21.7%), corticosteroid therapy (20%), and kidney insufficiency (18.3%) were the most common predisposing factors. 13.2% had neutropenia which was mostly among the non-diabetic patients (p=0.006). 23.2% endobronchial lesion had imaging reports with 33.9% exhibiting single mass. 76.7% pathological diagnosis used the transbronchial biopsy. The most frequent antifungal therapies were intravenous amphotericin B (79.7%), surgery (33.3%), and surgery combined with amphotericin B therapy (28.3%). Overall in-hospital mortality was 52.5%, with hemoptysis (p=0.017), dyspnea at presentation (p=0.022), and angioinvasion (p=0.03) as independent risk prognostic factors. In contrast, surgery (p=0.003) was an independent protection prognostic factor.

CONCLUSIONS
Tranchobronchial mucormycosis is a rare but severe disease with high mortality because of its nonspecific clinical presentations and variable predisposing factors. This article is protected by copyright. All rights reserved.

Submit a Comment

Your email address will not be published. Required fields are marked *

fourteen + two =

[ HIDE/SHOW ]